About paclitaxel 260 mg
Experience substantial savings and markdowns on our hot-selling Paclitaxel 260 mg injection, presented in a sublime 43.4 ml USP-compliant glass vial for intravenous use. This exquisite antineoplastic is manufactured to superb standards, offering a clear, colorless to pale yellow solution with no preservative. Carefully balanced at pH 3.0 - 4.0, it is perfect for the treatment of ovarian, breast, and non-small cell lung cancers. The cytotoxic, single-use sterile vial is compatible with DEHP-free infusion sets, and each dose promises excellence in quality and efficacy. Handle with care and entrust only to healthcare professionals.
Advanced Specifications and Versatile Application
Paclitaxel 260 mg stands out with its superb extra features: cytotoxic handling precautions, compatibility with DEHP-free infusion sets, and a shelf life of 24 months. Engineered for sterile, single-use applications, it is specially suitable for oncology suites and chemotherapy centers. This solution is superbly designed for precise dilution before IV administration, making it ideal for both hospital and clinical settings. Its sublime clarity and USP compliance ensure consistent safety and performance, reinforcing trust for healthcare professionals.
Global Reach and Seamless Transaction Assurance
Our main export markets for Paclitaxel 260 mg include dynamic regions across Asia, Africa, and Europe. Orders are processed efficiently to minimize outlay time, and products are expertly packaged in protective glass vials. Detailed export paperwork and secure shipment arrangements ensure each shipment is handed over safely. Sample policies are flexible to customer needs, making order processing straightforward for distributors, exporters, suppliers, and traders. Reliability and superb service are at the heart of our global business model.
FAQ's of paclitaxel 260 mg:
Q: How should Paclitaxel 260 mg be administered?
A: Paclitaxel 260 mg must be diluted with appropriate intravenous fluids before administration and given only through intravenous infusion by qualified healthcare professionals.
Q: What cancers can be treated with Paclitaxel 260 mg?
A: Paclitaxel 260 mg is indicated for use in ovarian cancer, breast cancer, and non-small cell lung cancer as part of comprehensive chemotherapy regimens.
Q: When should cytotoxic handling precautions be observed?
A: Cytotoxic handling precautions are required at every step-during preparation, administration, and disposal-due to the potent antineoplastic nature of Paclitaxel.
Q: Where should Paclitaxel 260 mg vials be stored?
A: The vials should be stored below 25C and protected from light to maintain stability and effectiveness throughout the 24-month shelf life.
Q: What is the process for ordering and receiving samples or bulk shipments?
A: Orders are processed promptly, and packaging is handled with utmost care. Samples and bulk shipments are handed over according to flexible sample policies, with comprehensive export documentation provided.
Q: What are the key features of the packaging and dosage form?
A: Each dose comes in a sterile, single-use glass vial containing a clear, colorless to pale yellow solution, meeting stringent USP compliance and compatible with DEHP-free infusion sets.